Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three ...

Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.

The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

However, the diagnostics segment accounted for the second-largest market share. Based on study type, the genomics market is segmented into functional genomics, biomarker discovery, pathway analysis, ...

The following is a summary of “Discovery and Validation of a Volatile Signature of Eosinophilic Airway Inflammation in Asthma ...

POINT is an innovative EU-funded project focused on advancing healthcare for individuals affected by Covid-19.

Company initiates process to explore a broad range of strategic alternatives to maximize shareholder valuePITTSBURGH, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: POAI), a science driven company ...

We are encouraged by the potential benefit of ALTO-100, as demonstrated in the adjunctive population, and of our biomarker approach in patients with confirmed drug compliance, showing that enrichment ...

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...

Furthermore, our presentations of preclinical and positive interim safety and biomarker data at key scientific conferences underscore the potential of PBFT02 to be a market leading progranulin-raising ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...